12:00 AM
May 14, 2012
 |  BC Week In Review  |  Company News  |  Management Tracks

Teva management update

Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), Petah Tikva, Israel
Business: Autoimmune, Neurology, Biosimilars
Hired: Michael Hayden as CSO and president...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >